Rational or Irrational: Polypharmacy in Psychiatry
Track:
Education Sessions (CE)
Program Code: 329-L01
Date: Tuesday, December 10, 2013
Time: 4:00 PM to 5:00 PM EST
Location:
W103 A, Level 1
PRESENTER(S):
Rex Lott
Sarah Melton
PROGRAM CHAIR:
Sarah Melton
Assess the benefits and potential toxicities associated with polypharmacy in patients with psychiatric disorders.
Describe the role of the Hospital-Based Inpatient Psychiatric Service (HBIPS) measures with regard to polypharmacy in the inpatient setting.
Discuss emerging advances in genetics and pharmacogenomics to tailor treatment and polypharmacy regimens in children and adults with psychiatric disorders.
Evaluate evidence-based literature regarding rational and irrational polypharmacy in psychiatric disorders.